NDC 61919-371
Ciprofloxacin 250 mg tablet
On the label: Direct Rx. It's repackaged: Direct Rx rebottles it from Rising Pharma Holdings, Inc.'s NDC 16571-411.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Unique Pharmaceutical Laboratories | Bharuch, India | Makes it and tests it | Problems found, fixed voluntarilyOct 23, 2022 · 6 inspections |
| Unique Pharmaceutical Laboratories | Bharuch, India | Makes it and tests it | No problems foundMar 7, 2025 · 2 inspections |
Repackaging site
- Direct Rx, Dawsonville, GA, United States · repackages it and relabels it
Recalls
- Mar 9, 2012 · Class III · Pack Pharmaceuticals
Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.
Lots: Lot #: : PUB1040, Exp 08/2015
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ciprofloxacin: every company that makes it
- Form
- tablet
- Strength
- 250 mg
- Approval
- ANDA ANDA076639
- On the market since
- Aug 14, 2019
- Package NDCs
61919-371-0661919-371-20- Official label
- DailyMed (National Library of Medicine), updated Apr 19, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?